A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/16420567

Download in:

View as

General Info

PMID
16420567